NCT02063126 - Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2013

Study Completion Date

December 31, 2013

Conditions

Chronic Fatigue Syndrome

Interventions

DIETARY_SUPPLEMENT

ReConnect (NADH plus CoQ10)

"ReConnect supplementation (NADH: 20 mg/day plus CoQ10: 200mg/day) divided into two daily dose ( 2 tablets/ before breakfast and 2 tablets/ before lunch)~Placebo supplementation divided into two daily dose ( 2 tablets/ before breakfast and 2 tablets/ before lunch)"

DIETARY_SUPPLEMENT

placebo

placebo (phosphoserine/serine plus vitamin C) supplementation divided in two daily doses (2 tablets/before brekfast and 2 tablets/before lunch)

Trial Locations (1)

08035

Vall Hebron University Hospital, Barcelona

All Listed Sponsors

collaborator

VITAE NATURAL NUTRITION, S.L.

UNKNOWN

lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER